BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8946583)

  • 1. Gene structure of ANCA target antigens: implications for the pathogenesis of vasculitis.
    Jenne DE
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):209-13. PubMed ID: 8946583
    [No Abstract]   [Full Text] [Related]  

  • 2. ANCA subsets: influence on disease phenotype.
    Specks U
    Cleve Clin J Med; 2002; 69 Suppl 2():SII56-9. PubMed ID: 12086266
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics of ANCA-associated vasculitides.
    Kallenberg CG; Rarok A; Stegeman CA
    Cleve Clin J Med; 2002; 69 Suppl 2():SII61-3. PubMed ID: 12086267
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis.
    Brockmann H; Schwarting A; Kriegsmann J; Petrow P; Gaumann A; Müller KM; Galle PR; Mayet W
    Arthritis Res; 2002; 4(3):220-5. PubMed ID: 12010574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the gene encoding proteinase-3 (the Wegener's granulomatosis autoantigen) to human chromosome band 19p13.3.
    Sturrock AB; Espinosa R; Hoidal JR; Le Beau MM
    Cytogenet Cell Genet; 1993; 64(1):33-4. PubMed ID: 8508676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human renal tubular epithelial cells as target cells for antibodies to proteinase 3 (c-ANCA).
    Schwarting A; Schlaak JF; Wandel E; Meyer zum Büschenfelde KH; Mayet WJ
    Nephrol Dial Transplant; 1997 May; 12(5):916-23. PubMed ID: 9175043
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetics and pathophysiology of granulomatosis with polyangiitis (GPA) and its main autoantigen proteinase 3.
    Relle M; Föhr B; Fasola F; Schwarting A
    Mol Cell Probes; 2016 Dec; 30(6):366-373. PubMed ID: 27559009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigen.
    Sturrock AB; Franklin KF; Rao G; Marshall BC; Rebentisch MB; Lemons RS; Hoidal JR
    J Biol Chem; 1992 Oct; 267(29):21193-9. PubMed ID: 1400430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
    Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
    Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L34. Neutrophils in ANCA-associated vasculitis: still under investigation.
    Witko-Sarsat V
    Presse Med; 2013 Apr; 42(4 Pt 2):595-7. PubMed ID: 23481359
    [No Abstract]   [Full Text] [Related]  

  • 12. L27. Antibodies versus phenotypes: a clinician's view.
    Jayne D
    Presse Med; 2013 Apr; 42(4 Pt 2):579-82. PubMed ID: 23490640
    [No Abstract]   [Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANCA--pathophysiology revisited.
    Kallenberg CG; Brouwer E; Mulder AH; Stegeman CA; Weening JJ; Tervaert JW
    Clin Exp Immunol; 1995 Apr; 100(1):1-3. PubMed ID: 7697907
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
    Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
    Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
    Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in pathogenesis and treatment of ANCA-associated vasculitis.
    Kallenberg CG
    Discov Med; 2014 Oct; 18(99):195-201. PubMed ID: 25336033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
    Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
    Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
    Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
    Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
    van der Geld YM; Stegeman CA; Kallenberg CG
    Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.